DNA research has been a hot issue worldwide in recent years, and one which culminated in the decoding of the DNA sequence of the entire human genome, accomplished by scientists from six countries in June.
In keeping with the global trend, Academia Sinica members last month urged the government to establish a Taiwanese gene database of Taiwan's ethnic groups for the purposes of medical research and further study of the diversity of human populations and languages.
But some researchers have expressed reservations about the plan, saying the database should be used only for disease research, not for ethnic studies, lest these give rise to political disputes.
PHOTO: CHEN CHENG-CHANG, TAIPEI TIMES
In addition, some say the classification of ethnic groups in Taiwan is based on a biased theory in the first place, and distorts the proportions of the population that different ethnic groups in Taiwan represent.
More importantly, the ethics of genetic research is of primary concern. It has been discussed in many other countries within the past decade and recently became controversial in Taiwan, particularly among Aborigines, who some say have been subject to gene sampling more than other ethnic groups in Taiwan.
Reflections on 'Gene Hunter'
The documentary tells of a group of American and British geneticists who visited tribes of American Indians to take blood samples. They told the native peoples that the research they were conducting was for health reasons and did not reveal their actual research motives.
"I was immediately shocked," Watan said, "but it's the same in Taiwan."
"Taiwanese Aborigines have been facing the same situation for decades, but no one pointed out the ethical problems before," he said.
Chen Shu-cho (陳叔倬), currently a lecturer at Tzu Chi College of Medicine and Humanities and former assistant on various genome projects, is also aware of the potential violation of Aborigines' human rights posed by genome research.
"No researcher told the people whose blood was taken why and how their blood would in fact be used," Chen said. "Different researchers told them the same thing: that their blood was to be used for a health check," he said.
"But why should a mere health check require so much blood?" Watan and Chen asked as they recounted how, although 3ml of blood was sufficient for a health check, many researchers drew between 10ml and 20ml and divided the blood into different tubes.
Three years ago, the former provincial health bureau implemented an overall health checkup for gout and liver diseases in Aboriginal areas. The researchers drew 10ml of blood from each person and divided it into three tubes.
"One tube for a gout check, one for liver diseases, and the third tube for what?" asked Watan.
"Some research centers and medical institutions have drawn many thousands of tubes totalling tens of thousands of milliliters of blood from Taiwanese Aborigines," Aboriginal lawmaker Tsai Chung-han (蔡中涵) said.
"Aborigines on Orchid Island had the worst experience," said Aboriginal physician Kao Cheng-chi (高正治), a former National Assembly member who worked as the director of a health center on Orchid Island.
Why do research centers and medical institutions focus on Aboriginal blood?
The Hypothesis for Aborigines
According to geneticists worldwide, there are two reasons to target Aboriginal blood. One is that researchers believe that Aborig-ines have purer heredity than the most people in mainstream societies worldwide, which, they believe, will enable them to obtain archetypal blood samples; the other is that researchers believe that Aborigines adopted distinct means of adapting to their environments and developed specific genes for fighting diseases.
Both reasons revolve around the isolation and long histories of Aboriginal societies.
In Taiwan, the government has officially identified nine ethnic groups of Aborigines. Some independent researchers claim there are at least twelve.
The languages, cultures and physical characteristics of members of Aboriginal groups vary. Due to these differences -- including their lower social status -- from Han Chinese (the main ethnic group in Taiwan), researchers consider them to be a distinct group.
Because they are considered to be distinct, Aborigines are often targeted for research into phenomena such as liver disease and gout.
Determining whether Taiwan is the origin of Austronesian peoples, including Australian Aborigines, is another question driving researchers to target Aborigines and one to which an answer has, as yet, remained elusive.
Researchers have tried different ways to trace the origin of Austronesian peoples. Eight years ago, HLA (Human Leukocyte Antigen) research became popular as a means of investigating the ethnic, genetic and cultural proximity between human populations.
HLA is one factor that can give researchers a way to measure such proximity. Taiwanese researchers found that the HLA of Aborigines showed a very high degree of species purity, in common with that of Austronesian peoples.
Academia Sinica, at the time this type of research became popular, launched a project on kinship and cultural relationships between Taiwanese Aborigines and South-east Asian indigenous peoples. Researchers visited the tribes, with the assistance of local health centers, on the pretext of health checks, Kao said, who was officially responsible for organizing the collecting of blood on Orchid Island at the time.
Orchid Islanders are widely thought to have the closest kinship with some Austronesian populations and were considered important to the research.
Last year, Aborigines again became the target of a research project. Researchers in Pintung Christian Hospital and Kaohsiung Medical College sought their blood for AIDS research. Acting on the hypothesis that Aborigines had some genome variation that counteracted HIV, since no death from AIDS among Aborigines had ever been recorded, the researchers planned to collect blood from 40,000 Aborigines.
Some Aborigines cast doubts on this plan. They said, according to an Aboriginal physician who declined to be named, that: "One reason for the low mortality from AIDS among Aborigines was their low population in Taiwan. Besides, many people have died of other related diseases rather than AIDS itself."
The first person known to have contracted HIV in Taiwan, Han Sen (
"There is greater solidarity among Aboriginal families than among many native Taiwanese families," Han Sen said. "We enjoy more support from the family."
"Moreover, the survival of AIDS patients hinges more on whether they can follow strict therapeutic regimes rather than anything else," stressed Han Sen, who has been working as a social worker in a center for AIDS patients since he contracted HIV.
The Lack of Informed Consent
Many whose blood is now being used for research never gave formal consent for its use, however, because of the way it was collected.
Since 1990, Mackay Memorial Hospital has used Aboriginal blood for genetic research. It has targeted 11 ethnic groups of Aborigines, 1377 individuals, and used red blood cells of 37 kinds of blood types.
In 1998, the Pintung County Government, on instructions from the former provincial health bureau and in cooperation with Pintung Christian Hospital, drew 10ml of blood from 1,900 Aborigines for health checks.
This year, the Taipei City Government's bureau of health will provide a one-day free health check for Aboriginal residents of Taipei over the age of 40. The health department plans to target around 1,900 Aborigines and accomplish the checkup in five municipal hospitals by September.
The purpose of this health check is to look into why Aborigines have an average lifespan that is 10 years shorter than that of Taiwanese of Han descent, according to officials in the health bureau.
All of the blood extracted for research purposes so far has been conducted along with free health checks, and mostly under the arrangement of official health centers.
Everyone concerned with genetic issues agrees that genetic research is helpful and beneficial to the well-being of people all over the world, especially from the point of view of improving overall health.
"But the problem is that researchers have only concentrated on the results and have overlooked the process," Chen said, adding that, "the research results also became the intellectual property of the researchers, with the Aborigines gaining nothing in return for their contributions."
The ethical principle of informed consent was ignored in all the above activities, Chen said.
Genome researchers in Taiwan are also criticized for misjudging how taking blood and carrying out genome research would be perceived by Aborigines, some of whose cultures may have taboos about the use of blood and body tissues.
More Ethical Concerns
In 1991, a group of international human geneticists and molecular biologists proposed a Human Genome Diversity Project (HGDP) to undertake a worldwide survey of the human genome.
HGDP planning workshops proposed guidelines on ethical issues, which included informed consent and benefits to contributing peoples.
"Should a patent be granted on any specific product, the project must work to ensure that the sampled populations benefit from the financial return from sales," said one of the guidelines.
Aboriginal communities worldwide, however, still voiced suspicion about the project. UNESCO decided not to start the project until it had acquired the trust of Aborigines worldwide.
Patents are another consideration affecting genome research among Aborigines. "If commercial goals are involved, genome research will be more complicated," Watan said.
"Taiwan should legislate to the effect that genome researchers may not apply for patents for their research results," said lawmaker Tsai.
Chen also pointed out that the Philippines, Bolivia, Columbia, Peru, and Venezuela -- where Aborigines constitute the majority of citizens -- have adopted laws monitoring the acquisition of genetic resources.
But there is no related legislation in Taiwan. The only related law is the Medical Treatment Law (
"This law, however, fails to regulate researchers mainly because of its limited definition," said Lin Chin-fen (
"Researchers argued that genome research was not research upon the human body," Lin said, adding, "Few researchers informed the DOH before they conducted health checks and drew blood from Aborigines."
The DOH's position within the government's hierarchy is another hindrance to the monitoring of this kind of genome research, Lin added.
Academia Sinica, the National Science Council and National Health Research Institute are the main institutions involved in genome research. "But the DOH's seniority within government is no higher than that of these organizations, which presents difficulties for it in its monitoring role."
"The DOH has suggested that the government organize a Cabinet-level ad hoc committee and incorporate an ethical protocol into legislation relating to research," Lin said. "The existing Medical Treatment Law should be expanded to cover genetic research and other research related to people."
PRIORITY GROUPS: A line of people were waiting at the Good Liver Clinic, apparently to get shots, while the CECC announced more priority groups for jabs The Taipei-based Good Liver Clinic is to be fined NT$2 million (US$72,028) after giving free COVID-19 vaccine shots to people not in groups eligible to receive them, Taipei Deputy Mayor Vivian Huang (黃珊珊) said yesterday. The Zhongshan District (中山)-based clinic was removed from the city’s list of vaccination venues and health officials would be investigated for giving 1,113 doses to the clinic, Huang told an afternoon news conference at Taipei City Hall. The Chinese-language Liberty Times (the Taipei Times’ sister paper) on Tuesday in an exclusive story citing an anonymous tip reported that a Taipei clinic was doling out unused vaccines. People in
PHASE 2: The firm’s CEO said that the results were good and the experimental vaccine safe, but added that hoped-for phase 3 trials would be expensive Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported positive results from an interim analysis of phase 2 trials for its COVID-19 vaccine, saying that the vaccine demonstrated high seroconversion rates and geometric mean titer (GMT) figures. A seroconversion rate is the percentage of participants in a trial displaying virus-specific immune memory after being given a vaccine, while the GMT measures the level of neutralizing antibody response, Medigen said. The experimental vaccine has a seroconversion rate of 99.8 percent and its GMT was 662 among the participants aged 20 to 89, while the gauges rose to 99.9 percent and 733 respectively in participants aged
NUMBERS HAVE FALLEN: Minister of Health and Welfare Chen Shih-chung said there are good signs, but ‘we cannot afford to let our guard down now’ The Central Epidemic Command Center (CECC) yesterday reported 219 new locally transmitted COVID-19 infections and 22 deaths. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that the 219 local infections — 117 male and 102 female — were aged from under five to over 100 years old, and they began having symptoms between May 22 and Monday. New Taipei City reported 123 cases, followed by Taipei with 54, Miaoli County with 16, Taoyuan with 13, Keelung with eight, Changhua County with two, and one each in Hsinchu City, Taichung and Tainan. The 22 deaths were 15 men and
ROLLING OUT DOSES: The expansion aims to speed up Taiwan’s vaccination drive by making more Moderna jabs available to workers at hospitals, the CECC said The Central Epidemic Command Center (CECC) yesterday expanded the eligibility for the Moderna COVID-19 vaccine to all healthcare workers and non-healthcare workers in the highest vaccine priority group. The center said that 75,000 doses of the vaccine — half of the first batch Taiwan has received — were on Wednesday distributed to hospitals across the nation with specialized COVID-19 rooms, negative pressure wards and testing services. Thus far, they had only been offered to frontline healthcare workers and non-healthcare workers at the designated hospitals, it said. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that the eligibility was